Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy

BACKGROUND: SGLT2-inhibitors are potent antihyperglycemic drugs for patients with type 2 diabetes and have been shown to reduce body weight. However, it is unclear which body compartments are reduced and to what extent. METHODS: In this longitudinal observational study, we analyzed the body composit...

Descripción completa

Detalles Bibliográficos
Autores principales: Schork, Anja, Saynisch, Janine, Vosseler, Andreas, Jaghutriz, Benjamin Assad, Heyne, Nils, Peter, Andreas, Häring, Hans-Ulrich, Stefan, Norbert, Fritsche, Andreas, Artunc, Ferruh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451223/
https://www.ncbi.nlm.nih.gov/pubmed/30953516
http://dx.doi.org/10.1186/s12933-019-0852-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451223/
https://www.ncbi.nlm.nih.gov/pubmed/30953516
http://dx.doi.org/10.1186/s12933-019-0852-y

Ejemplares similares